As discussed in this LipoVive review, the formula is a natural weight loss aid made with clinically approved herbs and plant compounds. The main target of the formula is to support quick and ...

Explore the latest biosimilar developments, including legislative changes, new approvals, and challenges in understanding, shaping the future of affordable health care.

Given trends in cost and use, insulin out-of-pocket cost reduction policies would be more efficient if they targeted members in high-deductible health plans with savings options and low-income ...

Pakistan is moving ahead with plans to import insulin from Russia through joint ventures between pharmaceutical companies ...

FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also ‘on notice’ PBMs owned by CVS, Cigna and UnitedHealth ‘artificially inflated’ prices for lifesaving ...

DexCom reports 15% Q2 2025 revenue growth, boosted by expanded type 2 diabetes access & product innovation. Discover their raised outlook & future plans.

Orr Inbar, CEO and co-founder of QuantHealth, unpacks the growing frustration over drug prices and the misperceptions fueling distrust in the pharmaceutical industry. With clinical trials now more ...

Led by Dr. Mark Prausnitz, Regents Professor of Chemical and Biomedical Engineering at Georgia Tech, the team engineered an ...

SCIENTISTS have suggested that stem cell therapy may offer a regenerative cure for type 1 diabetes (T1D).They said stem cell therapy could be used to regenerate cells of pancreas that produce insulin, ...

Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. Ozempic and Rybelsus helped Novo gain share over Eli Lilly's once-weekly ...

Eli Lilly will cut prices for some older insulins later this year and immediately expand a cap on costs insured patients pay to fill prescriptions. Lilly said it will cut the list price for its ...

While insulin price reductions are a notable victory, out-of-pocket costs for prescription medications continue to trend upward. Since 2014, prescription list prices have grown nearly 40%.